Kewaunee Scientific (NASDAQ:KEQU) CFO Donald Gardner III Sells 3,000 Shares

Kewaunee Scientific Corporation (NASDAQ:KEQU) CFO Donald Gardner III sold 3,000 shares of the business’s stock in a transaction on Thursday, October 9th. The stock was sold at an average price of $42.76, for a total transaction of $128,280.00. Following the completion of the sale, the chief financial officer owned 11,564 shares in the company, valued at $494,476.64. This represents a 20.60% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Kewaunee Scientific Trading Down 3.7%

Shares of KEQU opened at $41.53 on Friday. The company’s fifty day moving average is $50.32 and its 200 day moving average is $45.14. Kewaunee Scientific Corporation has a fifty-two week low of $30.33 and a fifty-two week high of $71.33. The stock has a market capitalization of $119.19 million, a PE ratio of 10.06 and a beta of 0.68. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.63 and a current ratio of 2.32.

Kewaunee Scientific (NASDAQ:KEQU) last announced its quarterly earnings results on Wednesday, September 10th. The technology company reported $1.10 earnings per share for the quarter. Kewaunee Scientific had a net margin of 4.68% and a return on equity of 25.65%. The company had revenue of $71.10 million for the quarter.

Institutional Trading of Kewaunee Scientific

Large investors have recently made changes to their positions in the stock. Bank of America Corp DE boosted its stake in shares of Kewaunee Scientific by 2,605.9% during the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock valued at $28,000 after purchasing an additional 443 shares during the period. IFP Advisors Inc boosted its stake in shares of Kewaunee Scientific by 61.5% during the first quarter. IFP Advisors Inc now owns 945 shares of the technology company’s stock valued at $37,000 after purchasing an additional 360 shares during the period. Raymond James Financial Inc. purchased a new stake in Kewaunee Scientific in the second quarter worth about $60,000. Wedbush Securities Inc. purchased a new stake in Kewaunee Scientific in the second quarter worth about $232,000. Finally, Morgan Dempsey Capital Management LLC lifted its stake in Kewaunee Scientific by 41.8% in the second quarter. Morgan Dempsey Capital Management LLC now owns 4,229 shares of the technology company’s stock worth $247,000 after acquiring an additional 1,247 shares during the period. 32.69% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have commented on KEQU shares. Wall Street Zen raised shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a research note on Saturday, July 5th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Kewaunee Scientific in a research note on Wednesday. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Kewaunee Scientific currently has an average rating of “Hold”.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.